You have 9 free searches left this month | for more free features.

adult myelodysplastic syndrome

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome Trial in United States (Chemotherapy)

Completed
  • Adult Acute Myeloid Leukemia
  • Adult Myelodysplastic Syndrome
  • Bozeman, Montana
  • +8 more
Feb 11, 2021

MDS Trial in Japan (Eltrombopag, Placebo)

Recruiting
  • Myelodysplastic Syndromes
  • Narita, Chiba, Japan
  • +21 more
Jan 19, 2023

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +13 more
  • CMVpp65-A*0201 peptide vaccine
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

Not yet recruiting
  • Myelodysplastic Syndrome
  • Beta Thalassemia
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

Not yet recruiting
  • Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • Tianjin, Tianjin, China
    Institute of Hematology&Blood Diseases Hospital,Chinese Academy
Jan 27, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Collecting and Storing Blood Samples From Patients With Cancer

Withdrawn
  • Brain and Central Nervous System Tumors
  • +10 more
    • (no location specified)
    Sep 20, 2021

    MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • IFN-γ (interferon gamma-1b) injection
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 5, 2023

    Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

    Recruiting
    • Myelodysplastic Syndromes
    • Blood test
    • Jerusalem, Israel
      Shaare Zedek Medical Center
    Nov 27, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022